What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies Picetti, Roberto; Shakur-Still, Haleema; Medcalf, Robert L.; More Picetti, Roberto; Shakur-Still, Haleema; Medcalf, Robert L.; Standing, Joseph F.; Roberts, Ian Less Blood Coagulation & Fibrinolysis. 30(1):1-10, January 2019. Abstract Abstract Favorites PDF Get Content & Permissions Abstract: Go to Full Text of this Article
Predicting mortality in patients with disseminated intravascular coagulation after cardiopulmonary bypass surgery by utilizing two scoring systems Demma, Linda J.; Faraoni, David; Winkler, Anne M.; More Demma, Linda J.; Faraoni, David; Winkler, Anne M.; Iba, Toshiaki; Levy, Jerrold H. Less Blood Coagulation & Fibrinolysis. 30(1):11-16, January 2019. Abstract Abstract Favorites PDF Get Content & Permissions Abstract:
Probable drug–drug interaction between dabigatran and quinidine resulting in thrombin time rebound despite multiple idarucizumab doses George, Stephy; Taburyanskaya, Margarita; Lewis, Vicky George, Stephy; Taburyanskaya, Margarita; Lewis, Vicky Less Blood Coagulation & Fibrinolysis. 30(1):42-46, January 2019. Abstract Abstract Favorites PDF Get Content & Permissions Abstract:
May restricted specificity of commercially available plasmin inhibitor activity assays affect correct diagnosis of antiplasmin deficiency? Pozzi, Loris; Della Valle, Patrizia; D’Angelo, Armando Pozzi, Loris; Della Valle, Patrizia; D’Angelo, Armando Less Blood Coagulation & Fibrinolysis. 30(1):52-53, January 2019. Favorites PDF Get Content & Permissions
